Search research articles
Contact Us
Filters
Showing results (411-420 of 498) with videos related to
Page
of 50
Sort By:
Journal of Cardiovascular Pharmacology
|
March 1, 1988
Nifedipine does not blunt the aldosterone and cardiovascular response to angiotensin II and potassium infusion in hypertensive patients
L Terzoli, G Leonetti, R Pedretti, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 1, 1983
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol
G Mancia, A Ferrari, G Pomidossi, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1991
Effect of acute and chronic administration of verapamil on cardiac structure and function in essential hypertension without left ventricular hypertrophy
C Cuspidi, L Sampieri, L Boselli, et al.
Journal of Cardiovascular Pharmacology
|
December 1, 1994
Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease
A Saino, G Pomidossi, R Perondi, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1988
Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension
C Sala, A Morganti, P Ferraris, et al.
Revista Espanola De Cardiologia
|
December 1, 1995
[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)]
G de Backer, I Graham, P Poole-Wilson, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|
January 22, 2002
An Italian chart for cardiovascular risk prediction. Its scientific basis
A Menotti, M Lanti, P E Puddu, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1993
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT)
M Ludwig, K O Stumpe, A M Heagerty, et al.
The American Journal of Cardiology
|
November 24, 1995
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT
K O Stumpe, M Ludwig, A M Heagerty, et al.
Clinical Science (London, England : 1979)
|
September 1, 1983
Plasma catecholamines do not invariably reflect sympathetically induced changes in blood pressure in man
G Mancia, A Ferrari, L Gregorini, et al.
Page
of 50
Search research articles
Search
Showing results (411-420 of 498) with videos related to
Sort By:
Page
of 50
Journal of Cardiovascular Pharmacology
|
March 1, 1988
Nifedipine does not blunt the aldosterone and cardiovascular response to angiotensin II and potassium infusion in hypertensive patients
L Terzoli, G Leonetti, R Pedretti, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 1, 1983
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol
G Mancia, A Ferrari, G Pomidossi, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1991
Effect of acute and chronic administration of verapamil on cardiac structure and function in essential hypertension without left ventricular hypertrophy
C Cuspidi, L Sampieri, L Boselli, et al.
Journal of Cardiovascular Pharmacology
|
December 1, 1994
Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease
A Saino, G Pomidossi, R Perondi, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1988
Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension
C Sala, A Morganti, P Ferraris, et al.
Revista Espanola De Cardiologia
|
December 1, 1995
[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)]
G de Backer, I Graham, P Poole-Wilson, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|
January 22, 2002
An Italian chart for cardiovascular risk prediction. Its scientific basis
A Menotti, M Lanti, P E Puddu, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1993
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT)
M Ludwig, K O Stumpe, A M Heagerty, et al.
The American Journal of Cardiology
|
November 24, 1995
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT
K O Stumpe, M Ludwig, A M Heagerty, et al.
Clinical Science (London, England : 1979)
|
September 1, 1983
Plasma catecholamines do not invariably reflect sympathetically induced changes in blood pressure in man
G Mancia, A Ferrari, L Gregorini, et al.
Page
of 50